1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses

2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact, adherence challenges, and nursing management

Real-world cardiovascular risks with novel hormonal therapies in advanced prostate cancer

QoL outcomes are inconsistently reported in contemporary phase III genitourinary cancer trials

Enhancing cancer care in Africa: Patient perspectives and quality improvement

Principles and practice of prognostication

Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG

Key updates on breast cancer treatments from ASCO 2025

Memorial Cancer Institute's Best of ASCO® 2025

Clinical advances in cancer molecular testing: the patient's perspective

Updates on gastrointestinal cancer treatments ASCO 2025

Unlocking biomarkers: Transforming immunotherapy outcomes